Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Ascend Wellness Holdings (AAWH) EBIAT (2020 - 2026)

Ascend Wellness Holdings has reported EBIAT over the past 6 years, most recently at -$48.7 million for Q4 2025.

  • For Q4 2025, EBIAT fell 190.05% year-over-year to -$48.7 million; the TTM value through Dec 2025 reached -$118.2 million, down 39.06%, while the annual FY2025 figure was -$118.2 million, 39.06% down from the prior year.
  • EBIAT for Q4 2025 was -$48.7 million at Ascend Wellness Holdings, down from -$25.8 million in the prior quarter.
  • Over five years, EBIAT peaked at $841000.0 in Q2 2023 and troughed at -$48.7 million in Q4 2025.
  • A 5-year average of -$22.7 million and a median of -$19.3 million in 2023 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: surged 103.97% in 2023 and later crashed 2690.25% in 2024.
  • Year by year, EBIAT stood at -$16.5 million in 2021, then rose by 8.85% to -$15.0 million in 2022, then decreased by 28.52% to -$19.3 million in 2023, then grew by 13.19% to -$16.8 million in 2024, then tumbled by 190.05% to -$48.7 million in 2025.
  • Business Quant data shows EBIAT for AAWH at -$48.7 million in Q4 2025, -$25.8 million in Q3 2025, and -$24.4 million in Q2 2025.